Back to News
Market Impact: 0.2
Marathon Fusion Publishes New Pathway for Scalable Production of Promising Cancer-Treatment Isotope Terbium-149
Source: PR Newswire
Healthcare & BiotechTechnology & InnovationProduct Launches
Marathon Fusion announced research proposing a stable gadolinium precursor that could resolve a decades-old isotope-supply bottleneck for producing terbium-149 (Tb-149). The approach could enable Tb-149 production using widely available medical cyclotrons, potentially broadening access to the medical isotope, though the announcement provides no commercialization timeline or financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
More News
- Key AI chip index just broke its long-term trendline. What history says happens next
- Banks, investors grow wary of AI debt, spooked by market selloff
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Musk says Tesla will refund some Cybertruck deposits, defends decision to end production
- Why is Nvidia’s Jensen Huang at the centre of a US-China spy scandal?
- CoreWeave confronts 'doom cycle' narrative as neocloud credit risk overshadows growth